The Supreme Court recently heard arguments regarding cancer warning labels for the popular weedkiller Roundup, a development that has sparked considerable debate and concern. At the heart of the matter lies the question of whether manufacturers of products like Roundup, specifically the glyphosate-based herbicide, should be required to warn consumers about potential cancer risks. This legal battle is far from straightforward, touching upon complex issues of corporate responsibility, scientific evidence, and even the very interpretation of free speech in relation to product labeling.
One of the most significant points of contention revolves around the scientific evidence linking glyphosate, the active ingredient in Roundup, to cancer.… Continue reading
A former groundskeeper who developed blood cancer after years of using Roundup is at the center of a Supreme Court case that will determine if Monsanto, its former manufacturer, can be sued for failing to warn about potential cancer risks associated with glyphosate. Despite the manufacturer’s claims that the weedkiller is safe and the Environmental Protection Agency’s stance against mandatory cancer warnings, public health groups and former EPA officials argue that the company should be held accountable for inadequate labeling. The case unfolds amidst a proposed class-action settlement that could resolve many lawsuits and a Trump administration executive order prioritizing domestic glyphosate production, creating a complex legal and political landscape surrounding the herbicide.
Read More
This section, curated by the independent Shopping Trends team, aims to provide readers with valuable insights and product recommendations. Please note that this team operates separately from CTV News journalists, and affiliate links within this content may result in commission earnings for Shopping Trends. These earnings support the continued provision of such shopping-related information.
Read More
The Supreme Court has agreed to hear Bayer’s appeal to block numerous state lawsuits concerning its Roundup weedkiller, specifically regarding failure to warn of potential cancer risks. The central issue is whether the Environmental Protection Agency’s approval of Roundup, without a cancer warning, preempts state court claims. Bayer, facing approximately 181,000 claims, argues for protection due to its compliance with federal regulations. The case stems from a Missouri jury’s award of $1.25 million to a man with non-Hodgkin’s lymphoma, and a previous Supreme Court decision declined a similar California case.
Read More
Georgia has enacted legislation shielding pesticide manufacturers, like Bayer, from lawsuits alleging failure to warn of potential dangers, mirroring a similar law in North Dakota. This law protects manufacturers adhering to federal labeling requirements, specifically impacting lawsuits against Bayer’s Roundup weed killer, which contains glyphosate. While the EPA considers glyphosate non-carcinogenic when used as directed, the law will not affect pre-existing litigation. Bayer, facing numerous lawsuits and significant financial settlements, actively supports such legislation alongside an extensive public relations campaign.
Read More
Bayer, a multinational pharmaceutical and life sciences company, has been ordered to pay a staggering $2.25 billion in damages after a jury linked their herbicide, Roundup, to cancer. As someone with a background in chemical engineering and scientific knowledge, I have some personal insights and opinions on this controversial issue.
Firstly, it is disheartening to see corporations like Bayer create subsidiaries to avoid paying the debts they owe. Johnson and Johnson’s bankruptcy maneuver serves as a reminder of the questionable practices that these companies resort to in order to evade their responsibilities. It is frustrating to witness the power that these corporations wield, seemingly above the law.… Continue reading
Matt Underwood 
John Q. Hosedrinker